Abstract
The use of oral poliovirus vaccine in a worldwide scale has led to a 99.9% decrease in annual incidence of wild-type poliomyelitis and the eradication of serotype 2 poliovirus. However, the emergence of vaccine-derived polioviruses (VDPVs) is endangering the eradication program. Patients with combined immunodeficiencies are at increased risk of both vaccine-associated poliomyelitis and prolonged asymptomatic infection with immunodeficiency-associated VDPVs (iVDPVs). Herein, we present a severe combined immunodeficiency patient with prolonged and asymptomatic iVDPV infection. He continued to shed poliovirus during immunoglobulin replacement therapy and cleared the infection following successful hematopoietic stem cell transplantation (HSCT). To explain the efficiency of HSCT in clearing the infection, we reviewed the literature for all reports of HSCT in iVDPV-excreting patients and discussed novel ideas about the role of different immune mechanisms, including cell-mediated interactions, in mounting immune responses against poliovirus infections. This study could provide further insights into the immune mechanisms contributing to the clearance of enteroviral infections.
Similar content being viewed by others
References
Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587–635. https://doi.org/10.1146/annurev.micro.58.030603.123625.
Morales M, Tangermann RH, Wassilak SG. Progress toward polio eradication—worldwide, 2015-2016. MMWR Morb Mortal Wkly Rep. 2016;65(18):470–3. https://doi.org/10.15585/mmwr.mm6518a4.
Minor PD. The polio-eradication programme and issues of the end game. J Gen Virol. 2012;93(3):457–74. https://doi.org/10.1099/vir.0.036988-0.
Khetsuriani N, Prevots DR, Quick L, Elder ME, Pallansch M, Kew O, et al. Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis. J Infect Dis. 2003;188(12):1845–52. https://doi.org/10.1086/379791.
Minor P. Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies. Dev Biol (Basel). 2001;105:75–80.
Alexander JP Jr, Gary HE Jr, Pallansch MA. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis. 1997;175(Suppl 1):S176–82.
Henderson DA, Witte JJ, Morris L, Langmuir AD. Paralytic disease associated with oral polio vaccines. JAMA. 1964;190:41–8.
CDC. Update on vaccine-derived polioviruses—worldwide, April 2011-June 2012. MMWR Morb Mortal Wkly Rep. 2012;61:741–6.
Sutter RW, Prevots DR. Vaccine-associated paralytic poliomyelitis among immunodeficient persons. Infect Med. 1994;11(6):426–38.
MacLennan C, Dunn G, Huissoon AP, Kumararatne DS, Martin J, O’Leary P, et al. Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet. 2004;363(9420):1509–13. https://doi.org/10.1016/s0140-6736(04)16150-3.
Dunn G, Klapsa D, Wilton T, Stone L, Minor PD, Martin J. Twenty-eight years of poliovirus replication in an immunodeficient individual: impact on the Global Polio Eradication Initiative. PLoS Pathog. 2015;11(8):e1005114. https://doi.org/10.1371/journal.ppat.1005114.
Tebbens RJD, Pallansch MA, Kew OM, Caceres VM, Jafari H, Cochi SL, et al. Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. Risk Anal. 2006;26(6):1471–505. https://doi.org/10.1111/j.1539-6924.2006.00827.x.
Alexander JP, Ehresmann K, Seward J, Wax G, Harriman K, Fuller S, et al. Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota. J Infect Dis. 2009;199(3):391–7. https://doi.org/10.1086/596052.
Robbins FC. Polio. Rochester: BOYE6; 1999.
Shaghaghi M, Shahmahmoodi S, Abolhassani H, Soleyman-Jahi S, Parvaneh L, Mahmoudi S, et al. Vaccine-derived polioviruses and children with primary immunodeficiency, Iran, 1995-2014. Emerg Infect Dis. 2016;22(10):1712–9. https://doi.org/10.3201/eid2210.151071.
Shaghaghi M, Soleyman-Jahi S, Abolhassani H, Yazdani R, Azizi G, Rezaei N, et al. New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data. Vaccine. 2018;36(13):1711–9. https://doi.org/10.1016/j.vaccine.2018.02.059.
New clinical diagnosis criteria for the ESID Registry. https://esid.org/Working-Parties/Registry/Diagnosis-criteria#. Accessed 12/28/2017.
Bousfiha A, Jeddane L, Al-Herz W, Ailal F, Casanova JL, Chatila T, et al. The 2015 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. 2015;35(8):727–38. https://doi.org/10.1007/s10875-015-0198-5.
Aghamohammadi A, Mohammadinejad P, Abolhassani H, Mirminachi B, Movahedi M, Gharagozlou M, et al. Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry. J Clin Immunol. 2014;34(4):478–90. https://doi.org/10.1007/s10875-014-0001-z.
Abolhassani H, Chou J, Bainter W, Platt CD, Tavassoli M, Momen T, et al. Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency. J Allergy Clin Immunol. 2018;141(4):1450–8. https://doi.org/10.1016/j.jaci.2017.06.049.
World Health Organization. Polio laboratory manual. 4th ed. WHO/IVB/04.10, 2004. http://www.who.int/iris/handle/10665/68762. Accessed 12/28/2017.
Aghamohammadi A, Abolhassani H, Kutukculer N, Wassilak SG, Pallansch MA, Kluglein S, et al. Patients with primary immunodeficiencies are a reservoir of poliovirus and a risk to polio eradication. Front Immunol. 2017;8:685. https://doi.org/10.3389/fimmu.2017.00685.
Macklin G, Liao Y, Takane M, Dooling K, Gilmour S, Mach O, et al. Prolonged excretion of poliovirus among individuals with primary immunodeficiency disorder: an analysis of the World Health Organization Registry. Front Immunol. 2017;8:1103. https://doi.org/10.3389/fimmu.2017.01103.
Jorba J, Diop OM, Iber J, Sutter RW, Wassilak SG, Burns CC. Update on vaccine-derived polioviruses—worldwide, January 2015-May 2016. MMWR Morb Mortal Wkly Rep. 2016;65(30):763–9. https://doi.org/10.15585/mmwr.mm6530a3.
Driss N, Mellouli F, Yahia AB, Touzi H, Barbouche MR, Triki H, et al. Sequential asymptomatic enterovirus infections in a patient with major histocompatibility complex class II primary immunodeficiency. J Clin Microbiol. 2014;52(9):3486–9. https://doi.org/10.1128/JCM.01122-14.
Schubert A, Böttcher S, Eis-Hübinger AM. Two cases of vaccine-derived poliovirus infection in an oncology ward. N Engl J Med. 2016;374(13):1296–8. https://doi.org/10.1056/NEJMc1508104.
de Koning C, Plantinga M, Besseling P, Boelens JJ, Nierkens S. Immune reconstitution after allogeneic hematopoietic cell transplantation in children. Biol Blood Marrow Transplant. 2016;22(2):195–206. https://doi.org/10.1016/j.bbmt.2015.08.028.
Oshrine BR, Li Y, Teachey DT, Heimall J, Barrett DM, Bunin N. Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood. Biol Blood Marrow Transplant. 2013;19(11):1581–9. https://doi.org/10.1016/j.bbmt.2013.08.003.
Booth C, Lawson S, Veys P. The current role of T cell depletion in paediatric stem cell transplantation. Br J Haematol. 2013;162(2):177–90. https://doi.org/10.1111/bjh.12400.
Chen X, Hale GA, Barfield R, Benaim E, Leung WH, Knowles J, et al. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. Br J Haematol. 2006;135(4):524–32. https://doi.org/10.1111/j.1365-2141.2006.06330.x.
Yazdani R, Sharifi M, Shirvan AS, Azizi G, Ganjalikhani-Hakemi M. Characteristics of innate lymphoid cells (ILCs) and their role in immunological disorders (an update). Cell Immunol. 2015;298(1–2):66–76. https://doi.org/10.1016/j.cellimm.2015.09.006.
Cherrier M. Innate lymphoid cells: new players of the mucosal immune response. Med Sci. 2014;30(3):280–8. https://doi.org/10.1051/medsci/20143003016.
Colonna M, Jonjic S, Watzl C. Natural killer cells: fighting viruses and much more. Nat Immunol. 2011;12(2):107–10. https://doi.org/10.1038/ni0211-107.
Driss N, Ben-Mustapha I, Mellouli F, Ben Yahia A, Touzi H, Bejaoui M, et al. High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies. Clin Vaccine Immunol. 2012;19(10):1684–9. https://doi.org/10.1128/cvi.00293-12.
Bae KW, Kim BE, Koh KN, Im HJ, Seo JJ. Factors influencing lymphocyte reconstitution after allogeneic hematopoietic stem cell transplantation in children. Korean J Hematol. 2012;47(1):44–52. https://doi.org/10.5045/kjh.2012.47.1.44.
Rouzaire P, Mayol K, Viel S, Bienvenu J, Walzer T. Homeostasis of natural killer cells. Med Sci. 2012;28(4):403–8. https://doi.org/10.1051/medsci/2012284018.
Yoon SR, Chung JW, Choi I. Development of natural killer cells from hematopoietic stem cells. Mol Cells. 2007;24(1):1–8.
Shaghaghi M, Parvaneh N, Ostad-Rahimi P, Fathi SM, Shahmahmoodi S, Abolhassani H, et al. Combined immunodeficiency presenting with vaccine-associated paralytic poliomyelitis: a case report and narrative review of literature. Immunol Investig. 2014;43(3):292–8. https://doi.org/10.3109/08820139.2013.859156.
Chiesa R, Gilmour K, Qasim W, Adams S, Worth AJ, Zhan H, et al. Omission of in vivo T-cell depletion promotes rapid expansion of naive CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant. Br J Haematol. 2012;156(5):656–66. https://doi.org/10.1111/j.1365-2141.2011.08994.x.
Lopez C, Biggar WD, Park BH, Good RA. Nonparalytic poliovirus infections in patients with severe combined immunodeficiency disease. J Pediatr. 1974;84(4):497–502.
MacCallum FO. Hypogammaglobulinaemia in the United Kingdom. VII. The role of humoral antibodies in protection against and recovery from bacterial and virus infections in hypogammaglobulinaemia. Spec Rep Ser Med Res Counc (G B). 1971;310:72–85.
Sutter RW, Suleiman AJ, Malankar P, Al-Khusaiby S, Mehta F, Clements GB, et al. Trial of a supplemental dose of four poliovirus vaccines. N Engl J Med. 2000;343(11):767–73. https://doi.org/10.1056/NEJM200009143431103.
Barbouche MR, Galal N, Ben-Mustapha I, Jeddane L, Mellouli F, Ailal F, et al. Primary immunodeficiencies in highly consanguineous North African populations. Ann N Y Acad Sci. 2011;1238:42–52. https://doi.org/10.1111/j.1749-6632.2011.06260.x.
Rezaei N, Pourpak Z, Aghamohammadi A, Farhoudi A, Movahedi M, Gharagozlou M, et al. Consanguinity in primary immunodeficiency disorders; the report from Iranian Primary Immunodeficiency Registry. Am J Reprod Immunol. 2006;56(2):145–51. https://doi.org/10.1111/j.1600-0897.2006.00409.x.
Acknowledgments
We thank Ahmad Nejati, Maryam Yousefi, Yaghoob Mollaie, and all the staff members of the Iran National Polio Laboratory and also CDC-Atlanta for performing thorough virologic studies.
This study was done at the Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran. The Iran National Polio Laboratory is supported by the Ministry of Health and Medical Education, the World Health Organization, and Tehran University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Shaghaghi, M., Irannejad, M., Abolhassani, H. et al. Clearing Vaccine-Derived Poliovirus Infection Following Hematopoietic Stem Cell Transplantation: a Case Report and Review of Literature. J Clin Immunol 38, 610–616 (2018). https://doi.org/10.1007/s10875-018-0521-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-018-0521-z